China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China NT Pharma Group has announced a delay in the distribution of a crucial circular related to a connected transaction involving loan capitalization and share subscription, originally expected by December 2024. The company has applied for an extension until January 2025 to finalize the circular’s contents, which are essential for proceeding with the transaction. The completion of this transaction hinges on the approval of a Whitewash Waiver by the Executive and the company’s Independent Shareholders.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.